Effect of 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol on Immune Functions in Healthy Adults in a Randomized Controlled Trial
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
We previously reported that 1-palmitoyl-2-linoleoyl-3- acetyl-rac-glycerol (PLAG) accelerates hematopoiesis and has an improving effect on animal disease models such as sepsis and asthma. The effects of PLAG supplementation on immune modulation were assessed in healthy men and women. The objective was to evaluate the effects of PLAG supplementation on immune regulatory functions such as activities of immune cells and cytokine production. A randomized double blind placebo-controlled trial was conducted. Seventy-five participants were assigned to one of two groups; all participants had an appropriate number of white blood cells on the testing day. The PLAG group (n=27) received oral PLAG supplements and the control group (n=22) received oral soybean oil supplements. IL-4 and IL-6 production by peripheral blood mononuclear cells (PBMC) were lower (p＜0.001 and p＜0.001, respectively) with PLAG than with soybean oil. However, the production of IL-2 and IFN-γ by PBMC was unaltered with PLAG supplementation. The B cell proliferation decreased significantly in the PLAG group compared to the soybean oil control (p＜0.05). The intake of PLAG in healthy adults for 4 weeks was deemed safe. These data suggest that PLAG has an immunomodulatory function that inhibits the excessive immune activity of immunological disorders such as atopic and autoimmune diseases. PLAG could improve the condition of these diseases safely as a health food supplement.
Abstract
We previously reported that 1-palmitoyl-2-linoleoyl-3- acetyl-rac-glycerol (PLAG) accelerates hematopoiesis and has an improving effect on animal disease models such as sepsis and asthma. The effects of PLAG supplementation on immune modulation were assessed in healthy men and women. The objective was to evaluate the effects of PLAG supplementation on immune regulatory functions such as activities of immune cells and cytokine production. A randomized double blind placebo-controlled trial was conducted. Seventy-five participants were assigned to one of two groups; all participants had an appropriate number of white blood cells on the testing day. The PLAG group (n=27) received oral PLAG supplements and the control group (n=22) received oral soybean oil supplements. IL-4 and IL-6 production by peripheral blood mononuclear cells (PBMC) were lower (p＜0.001 and p＜0.001, respectively) with PLAG than with soybean oil. However, the production of IL-2 and IFN-γ by PBMC was unaltered with PLAG supplementation. The B cell proliferation decreased significantly in the PLAG group compared to the soybean oil control (p＜0.05). The intake of PLAG in healthy adults for 4 weeks was deemed safe. These data suggest that PLAG has an immunomodulatory function that inhibits the excessive immune activity of immunological disorders such as atopic and autoimmune diseases. PLAG could improve the condition of these diseases safely as a health food supplement.
참고문헌 (36)
- Wu, F., "Deer antler base as a traditional Chinese medicine: a review of its traditional uses, chemistry pharmacology", J. Ethnopharmacol, 145, pp.403~415 (2013)
- Gilbey, A., "Health benefits of deer elk velvet antler supplements: a systematic review of randomised controlled studies", N. Z. Med. J, 125, pp.80~86 (2012)
- Allen, M., "A randomized clinical trial of elk velvet antler in rheumatoid arthritis", Biol. Res. Nurs, 9, pp.254~261 (2008)
- Yang, H. O., "Stimulatory effects of monoacetyldiglycerides on hematopoiesis", Biol. Pharm. Bull, 27, pp.1121~1125 (2004)
- Kleiman, R., "Optically active aceto-triglycerides of oil fromEuonymus verrucosus seed", Lipids, 1, pp.286~287 (1966)
- Myher, J. J., "Identification of the more complex triacylglycerols in bovine milk fat by gas chromatography-mass spectrometry using polar capillary columns", J. Chromatogr, 452, pp.93~118 (1988)
- Limb, J. K., "Isolation characterization of monoacetyldiglycerides from bovine udder", J. Lipid Res, 40, pp.2169~2176 (1999)
- Yang, H. O., "Purification structural determination of hematopoietic stem cell-stimulating monoacetyldiglycerides from Cervus nippon (deer antler)", Chem. Pharm. Bull, 52, pp.874~878 (2004)
- 김명환, "EC-18, a Synthetic Monoacetyldiacylglyceride, Inhibits Hematogenous Metastasis of KIGB-5 Biliary Cancer Cell in Hamster Model", Journal of Korean Medical Science, 24(3), pp.474~480 (2009), 대한의학회
- Hong, J. J., "Enteral administration of a synthetic monoacetyldiglyceride improves survival in a murine model of abdominal sepsis. J", Trauma, 68, pp.62~68 (2010)
- Shin, I. S., "EC-18, a synthetic monoacetyldiglyceride (1-palmitoyl-2-linoleoyl-3-acetylglycerol), attenuates the asthmatic response in an aluminum hydroxide", ovalbumin-induced model of asthma, 2014, pp.18, 116~123
- Barrett, N. A., "Innate cells T helper 2 cell immunity in airway inflammation", Immunity, 31, pp.425~437 (2009)
- Doherty, T., "Cytokines growth factors in airway remodeling in asthma", Curr. Opin. Immunol, 19, pp.676~680 (2007)
- Walford, H. H., "Diagnosis management of eosinophilic asthma: a US perspective", Asthma Allergy, 7, pp.53~65 (2014)
- Isidoro-Garcia, M., "Interleukin-4 (IL4) Interleukin-4 receptor (IL4RA) polymorphisms in asthma: a case control study", Clin. Mol. Allergy, 3, pp.15~ (2005)
- Kumar, V. A., "Inflammation Repair. Basic Pathology", pp.53~ (2012), Elsevier
- Gor, D. O., "TH1-TH2:a procrustean paradigm", Nat. Immunol, 4, pp.503~505 (2003)
- Romagnani, S., "Biology of human TH1 TH2 cells", J. Clin. Immunol, 15, pp.121~129 (1995)
- Cher, D. J., "Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones", J. Immunol, 138, pp.3688~3694 (1987)
- O'Garra, A., "Cytokines induce the development of functionally heterogeneous T helper cell subsets", Immunity, 8, pp.275~283 (1998)
- Onoe, K., "Th1 or Th2 balance regulated by interaction between dendritic cells NKT cells", Immunol. Res, 38, pp.319~332 (2007)
- Kidd, P., "Th1", Th2 balance: the hypothesis, its limitations, implications for health disease, 2003, pp.8, 223~246
- Kaminogawa, S., "Modulation of Immune Functions by Foods", Evid. Based Complement Alternat. Med, 1, pp.241~250 (2004)
- Kristiansen, O. P., "Interleukin-6diabetes: the good, the bad, or the indifferent?", Diabetes, 54(Suppl 2), pp.S114~S124 (2005)
- Dubinski, A., "The role of interleukin-6in development progression of atherosclerosis", Pol. Merkur. Lekarski, 22, pp.291~294 (2007)
- Swardfager, W., "A meta-analysis of cytokines in Alzheimer's disease", Biol. Psychiatry, 68, pp.930~941 (2010)
- Tackey, E., "Rationale for interleukin-6 blockade in systemic lupus erythematosus", Lupus, 13, pp.339~343 (2004)
- Nishimoto, N., "Interleukin-6 in rheumatoid arthritis", Curr. Opin. Rheumatol, 18, pp.277~281 (2006)
- Song, M., "Interleukin-6", Crit. Care Med, 33, pp.S463~S465 (2005)
- Smith, P. C., "Interleukin-6 prostate cancer progression", Cytokine Growth Factor Rev, 12, pp.33~40 (2001)
- Tschaikowsky, K., "Predictive value of procalcitonin, interleukin-6, C-reactive protein for survival in postoperative patients with severe sepsis", J. Crit. Care, 26, pp.54~64 (2011)
- Zipfel, P. F., "Complement regulators inhibitory proteins", Nat. Rev. Immunol, 9, pp.729~740 (2009)
- Ricklin, D., "Complement: a key system for immune surveillance homeostasis", Nat. Immunol, 11, pp.785~797 (2010)
- Pio, R., "Complement inhibition in cancer therapy", Semin. Immunol, 25, pp.54~64 (2013)
- Risitano, A. M., "Peptide inhibitors of C3 activation as a novel strategy of complement inhibition for the treatment of paroxysmal nocturnal hemoglobinuria", Blood, 123, pp.2094~2101 (2014)
- Hammond, E. G., "Soybean oil. Bailey's Industrial Oil Fat Products", pp.2~13 (2005), John Wiley & Sons, Inc